The document discusses a study that evaluated the correlation between the TIMI risk score, a tool used to predict risks of death and other ischemic events in patients with non-ST elevation acute coronary syndromes, and high-risk angiographic findings in those patients. The study used data from 1491 patients in the PRISM-PLUS trial, finding a relationship between higher TIMI risk scores at presentation and more severe thrombus, worse epicardial blood flow, and more severe coronary lesions seen on angiography.